Bone Marrow TransplantationTransplantation, HomologousGraft vs Host DiseaseWhole-Body IrradiationBone MarrowBone Marrow CellsAnemia, AplasticBusulfanHematopoietic Stem Cell TransplantationLeukemiaHematopoietic Stem CellsTransplantation, AutologousHistocompatibility TestingGraft vs Host ReactionTransplantation ConditioningCyclophosphamideTransplantation ChimeraLiver TransplantationGraft SurvivalMethotrexateTissue DonorsRecurrenceHistocompatibilityCytomegalovirus InfectionsHematopoiesisKidney TransplantationHematologic NeoplasmsTransplantation, IsogeneicBone and BonesBone Marrow PurgingGraft RejectionStem Cell TransplantationImmunosuppressive AgentsLeukemia, Myelogenous, Chronic, BCR-ABL PositiveMice, Inbred C57BLTreatment OutcomeCombined Modality TherapyImmunosuppressionFollow-Up StudiesLeukemia, Myeloid, AcuteLymphocyte DepletionRadiation ChimeraTime FactorsBone Marrow DiseasesTransplantation ImmunologyHeart TransplantationStem CellsAcute DiseaseT-LymphocytesRemission InductionHLA AntigensSurvival AnalysisHepatic Veno-Occlusive DiseasePrecursor Cell Lymphoblastic Leukemia-LymphomaColony-Forming Units AssayNuclear FamilyRetrospective StudiesCyclosporineLung TransplantationLeukemia, MyeloidBone Marrow ExaminationLeukocyte TransfusionMyelodysplastic SyndromesLymphoma, Non-HodgkinAntigens, CD34Cell DifferentiationSevere Combined ImmunodeficiencyChimeraOrgan TransplantationHematologic DiseasesBone Marrow NeoplasmsGraft vs Tumor EffectGraft vs Leukemia EffectHematopoietic Stem Cell MobilizationFlow CytometryCord Blood Stem Cell TransplantationInfectionActuarial AnalysisSurvival RateGranulocyte Colony-Stimulating FactorLymphocyte TransfusionCells, CulturedSpleenCell TransplantationAntineoplastic Combined Chemotherapy ProtocolsPeripheral Blood Stem Cell TransplantationCyclosporinsMice, Inbred BALB CPancytopeniaChimerismCarmustineLeukocyte CountCell LineageCytarabineIslets of Langerhans TransplantationMelphalanCell SeparationCystitisMultiple MyelomaTransplantation